Studies on multidrug-resistant microorganisms, especially Escherichia coli (E. coli) strains, continue worldwide. In addition to the discovery of new antibiotics, there is also significant research onresistance mechanisms. One such mechanism is the efflux pump, which rapidly expels substances (antibiotics) from the bacterial cell or reduces their concentration. Therefore, the effectiveness of antibiotics can be restored by preventing this mechanism, and studies on potential inhibitors in this direction are ongoing.
In this study, the potential inhibitory effect of acetone extract obtained from Phellinus hartigii (P. hartigii) against drug-resistant E. coli strains was investigated. This was done by using the extract incombination with the antibiotics aztreonam (ATM 30 μg), cefixime (CFM 5 μg), amoxicillin–clavulanate (AMC 30 μg), piperacillin–tazobactam (TZP 36 μg), and ceftriaxone (CRO 30 μg) (Oxoid, UK).
For the first stage of inhibition, the Ethidium Bromide (EtBr) test was used with P. hartigii acetone extract. After observing inhibition according to the test results, antibiotic disks were applied together with the extract, antibiotic, and resistant strains. As a result of this study, it was observed that activities against E. coli #3 strain ATM (MIC 4), E. coli #10 strain ATM (MIC 8), E. coli #7 strain TZP (MIC >16/4), and E. coli #8 strain TZP (MIC >16/4) were restored. Based on these findings, P. hartigii acetone extract may have a potential efflux pump inhibitory eff ect, but further studies are required to explain this effect more broadly.
García-Castro, M., Sarabia, F., Díaz-Morilla, A., & López-Romero, J. M. (2023). Approved antibacterial drugs in the last 10 years: From the bench to the clinic. Exploratory Drug Science, 1, 180–209.
Zhang, L., Tian, X., Sun, L., Mi, K., Wang, R., Gong, F., & Huang, L. (2024). Bacterial efflux pump inhibitors reduce antibiotic resistance. Pharmaceutics, 16, 170.
Lamut, A., Peterlin Mašić, L., Kikelj, D., & Tomašić, T. (2019). Efflux pump inhibitors of clinically relevant multidrug resistant bacteria. Medicinal Research Reviews, 39, 2460–2504.
Laws, M., Jin, P., & Rahman, K. M. (2022). Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance. Trends in Microbiology, 30, 57–68.
Altinöz, E., & Altuner, E. M. (2019). Antibiotic resistance and efflux pumps. International Journal of Innovative Research and Reviews (INJIRR), 3(2), 1–9. file/995486
Altinöz, E., & Altuner, E. M. (2022). Observing the presence of efflux pump activities in some clinically isolated bacterial strains. International Journal of Biology and Chemistry, 15(1), 48–54.
Altinöz, E., Akata, E., & Altuner, E. M. (2024). Molecular docking application for the potential use of palmitic acid as an AcrB, an efflux pump protein, inhibitor. In Horizons of Innovation: Conference on Multidisciplinary Trends in Science 2024 (pp. 352-356). Futurity Research Publishing.
Altınöz, E., & Altuner, E. M. (2020). Responses of some Escherichia coli clinical isolate strains with multiple drug resistance and overexpressed efflux pumps against efflux pump inhibitors. International Journal of Biology and Chemistry, 13(1), 77-87.
Du, D., Wang, Z., James, N. R., Voss, J. E., Klimont, E., Ohene-Agyei, T., ... & Luisi, B. F. (2014). Structure of the AcrAB-TolC multidrug efflux pump. Nature, 509(7501), 512–515.
Szal, T., Chauhan, S. S., Lewe, P., Rachad, F., Madre, M., Paunina, L., ... & Windshügel, B. (2023). Efflux pump-binding 4 (3-aminocyclobutyl) pyrimidin-2-amines are colloidal aggregators. Biomolecules, 13(6), Article 1000.
Mahey, N., Tambat, R., Chandal, N., Verma, D. K., Thakur, K. G., & Nandanwar, H. (2021). Repurposing approved drugs as fluoroquinolone potentiators to overcome efflux pump resistance in Staphylococcus aureus. Microbiology Spectrum, 9, e0095121.
Duffey, M., Jumde, R. P., da Costa, R. M., Ropponen, H. K., Blasco, B., & Piddock, L. J. (2024). Extending the potency and lifespan of antibiotics: Inhibitors of gram-negative bacterial efflux pumps. ACS Infectious Diseases, 10(5), 1458-1482.
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17.
Lee, S. K., Chang, G. S., Lee, I. H., Chung, J. E., & Sung, K. Y. (2004). The PreADME: PC-based program for batch prediction of ADME properties. EuroQSAR, 9, 5–10.
Yang, H., Lou, C., Sun, L., Li, J., Cai, Y., Wang, Z., & others. (2019). AdmetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties. Bioinformatics, 35, 1067–1069.